Skip to main content
. Author manuscript; available in PMC: 2008 Feb 4.
Published in final edited form as: FASEB J. 2007 Feb 27;21(8):1788–1800. doi: 10.1096/fj.06-7451com

Figure 6.

Figure 6

I/R increases hepatic endocannabinoid levels. A) Endocannabinoid (anandamide [AEA], 2-arachidonoylglycerol [2-AG] and oleoylethanolamide [OEA]) levels in liver tissue in sham mice (n=19) and in mice exposed to 60 min ischemia (I; n=5) or 60/90 min I/R (I/R; n=13). B) Endocannabinoid levels in hepatocytes isolated from sham (n=8) or 60/90 min I/R-exposed mice (n=6). Each experiment represents a pool of 2 animals. C) Endocannabinoid levels in Kupffer cell/endothelial cell fraction isolated from sham (n=4) or I/R-exposed mice (n=5). Each experiment represents a pool of 6–8 animals. (*P<0.05 sham vs. I/R).